Back to Agenda
Session 2: Adaptive Pathways and Innovative Medicines Development for Improved Access
Session Chair(s)
Solange Corriol-Rohou, DrMed, MD, PHD
, SCR Consulting, France
Speaker(s)
Jacoline Bouvy, PHD
Scientific Adviser, Science Policy and Research Programme, National Institute for Health and Care Excellence (NICE), United Kingdom
Adaptive Pathways: An HTA Perspective
Claudine Sapède, PHARMD
Director, Global HTA Policy, NOVARTIS INTERNATIONAL, Switzerland
Adaptive Pathways: An Industry’s Perspective
Richard Barker, PHD
Founding Director, Centre for the Advancement of Sustainable Medical Innovation (CASMI), United Kingdom
Rosa Giuliani, MD
Consultant in Medical Oncology, S. Camillo-Forlanini Hospital, Italy, European Society for Medical Oncology (ESMO), Switzerland
Adaptive Pathways: A Clinician's Perspective
Have an account?
